NON-NEUROTOXIC PLASMINOGEN ACTIVATING FACTORS FOR TREATING OF STROKE
The invention concerns the use and the production of non-neurotoxic plasminogen activating factors, derived, for example, from the common vampire Desmodus rotundus (DSPA), for therapeutic treatment of stroke in humans. The invention provides a novel therapeutic base for treating stroke in humans.
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
14.02.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!